Investing Profile
Cory Freedland
Your Intro Paths to Cory Freedland
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Cory Freedland on
cbCurrent Investing Position
Samsara BioCapital Principal
Investment Range
$1M - $100.0M
Sweet Spot
$25.0M
Investments On Record
3
Current Fund Size
$310.1M
Cory Freedland is on these Sector & Stage Rankings
Pharmaceuticals (Series B)Pharmaceuticals (Series A)Pharmaceuticals (Seed)Pharmaceuticals (Series B)Health & Hospital Services (Series B)BioTech (Series B)Health IT (Series B)BioTech (Seed)Health & Hospital Services (Seed)Health IT (Series A)BioTech (Series A)Pharmaceuticals (Seed)Pharmaceuticals (Series A)BioTech (Series B)Health & Hospital Services (Series A)Health IT (Seed)Health & Hospital Services (Series B)BioTech (Series A)Health IT (Series B)Health & Hospital Services (Series A)BioTech (Seed)Health IT (Series A)Health & Hospital Services (Seed)Health IT (Seed)San Francisco Bay Area
Cory Freedland's Investments On Record (3)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Alpha9 Theranostics | Series BDec 2022$75M | $75M |
Palvella Therapeutics | Series CMay 2020$45M | $45M |
Velicept Therapeutics | Series BOct 2018$15M  | $15M |
Investors who invest with Cory Freedland